Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Sinco Pharmaceuticals Holdings Ltd. ( (HK:6833) ) just unveiled an update.
Sinco Pharmaceuticals Holdings Ltd. announced a supplemental update regarding a previously issued interest-free loan of HK$5 million to Mr. Huang Xiangbin, a connected person, during the COVID-19 pandemic. The loan, approved by the company’s CFO and CEO, was deemed necessary due to operational instability caused by the pandemic. The company’s board has conducted a thorough review and confirmed that this loan was an isolated incident, with no similar transactions occurring from 2020 to 2024, ensuring transparency and compliance with regulatory standards.
More about Sinco Pharmaceuticals Holdings Ltd.
Sinco Pharmaceuticals Holdings Ltd. is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. The company focuses on developing and providing pharmaceutical products and services, although specific market focus details are not provided in the release.
Average Trading Volume: 211,740
Technical Sentiment Signal: Hold
Current Market Cap: HK$426.9M
Find detailed analytics on 6833 stock on TipRanks’ Stock Analysis page.